Incidence of Open-angle Glaucoma in Newly Diagnosed Retinal Vein Occlusion: A Nationwide Population-based Study.
Summary
The incidence rate of OAG in patients with RVO is significantly higher than that in the general population.
Abstract
PURPOSE
The purpose of this study was to compare the incidence of open-angle glaucoma (OAG) in patients with newly diagnosed retinal vein occlusion (RVO) with that in the general population in order to determine the association between OAG and RVO.
METHODS
The Korean Health Insurance Review and Assessment (HIRA) data from 2011 through 2015 was analyzed in order to determine the incidence rates of OAG in the general population and in patients with newly diagnosed RVO based on the diagnostic code. The standardized incidence ratios (SIRs) of OAG in patients with RVO were determined with respect to the age- and sex-matched general population.
RESULTS
The incidence rate of OAG in the general population during the 3 years (2013 to 2015) was 233.98 per 100,000 person-years (95% CI, 233.21-234.76). A total of 31,722 patients with newly diagnosed RVO were identified in 2012 as the population at risk. The incidence rate of OAG in patients with RVO during the 3-year follow-up period was 1829.43 per 100,000 person-years (95% CI, 1745.49-1917.42). The expected incidence of OAG in patients with RVO was 433.69 during the 3-year follow-up period. On the other hand, the observed incidence of OAG was 1,741. The SIR of OAG in patients with RVO with reference to the general population was 4.01 (95% CI, 3.83-4.20).
CONCLUSIONS
The incidence rate of OAG in patients with RVO is significantly higher than that in the general population.
More by Kyeong Ik Na
View full profile →Temporal Relation between Macular Ganglion Cell-Inner Plexiform Layer Loss and Peripapillary Retinal Nerve Fiber Layer Loss in Glaucoma.
Diagnostic Ability of Wide-field Retinal Nerve Fiber Layer Maps Using Swept-Source Optical Coherence Tomography for Detection of Preperimetric and Early Perimetric Glaucoma.
Combined Use of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Event-based Progression Analysis.
Top Research in Epidemiology & Genetics
Browse all →The Risks and Benefits of Myopia Control.
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Neuroprotective strategies for retinal disease.
Discussion
Comments and discussion will appear here in a future update.